Allantoin improves methionine-choline deficient diet-induced nonalcoholic steatohepatitis in mice through involvement in endoplasmic reticulum stress and hepatocytes apoptosis-related genes expressions

Document Type : Original Article

Authors

1 Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran

2 Student Research Committee, Qom University of Medical Sciences, Qom, Iran

Abstract

Objective(s): Non-alcoholic steatohepatitis (NASH) is defined by steatosis and inflammation in the hepatocytes, which can progress to cirrhosis and possibly hepatocellular carcinoma. However, current treatments are not entirely effective. Allantoin is one of the principal compounds in many plants and an imidazoline I receptor agonist as well. Allantoin has positive effects on glucose metabolism and inflammation. In this study, the effects of allantoin on the NASH induced animals and the pathways involved have been evaluated.
Materials and Methods: C57/BL6 male mice received saline and allantoin as the control groups. In the next group, NASH was induced by the methionine-choline-deficient diet (MCD) for eight weeks. In the NASH+allantoin group, allantoin was injected four weeks in the mice feeding on an MCD diet. Histopathological evaluations, serum analysis, ELISA assay, and real-time RT-PCR were performed.
Results: Allantoin administration decreased serum alanine aminotransferase (ALT), cholesterol, low-density lipoprotein (LDL), hepatic lipid accumulation, and liver tumor necrosis factor (TNFα) level. Also, treatment with allantoin down-regulated the gene expression of glucose-regulated protein 78 (GRP78), activating transcription factor 6 (AFT6), TNFα, sterol regulatory element binding proteins 1c (SREBP1c), fatty acid synthase (FAS), Bax/Bcl2 ratio, caspase3, and P53. On the other hand, peroxisome proliferator-activated receptor alpha (PPARα), apolipoprotein B (Apo B), and acetyl-coenzyme acetyltransferase 1 (ACAT1) gene expression increased after allantoin injection.
Conclusion: This study indicated that allantoin could improve animal induced NASH by changes in the expression of endoplasmic reticulum stress-related genes and apoptotic pathways.

Keywords

Main Subjects

References

1. Fuchs CD, Claudel T, Kumari  P, Haemmerle G, Pollheimer MJ, Stojakovic T, et al. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology  2012; 56: 270–280.
2. Henao M J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185.
3. Zhu JZ, Dai YN, Wang YM, Zhou QY, Yu CH, Li YM. Prevalence of nonalcoholic fatty liver disease and economy. Dig Dis Sci 2015; 60: 3194-3202.
4. Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci 2016; 73: 1969-1987.
5. Chen C, Liu Q, Liu L, Hu YY, Feng Q. Potential biological effects of (-)-Epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease. Mol Nutr  Food  Res  2018; 62:45-47.
6. Ibrahim S H, Hirsova P, Gores GJ. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut 2018; 2017: 315691-315697.
7. Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and  new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci 2014; 15: 7352-7379.
8. Zhang J, Zhang H, Deng X, Zhang N, Liu B, Xin S, et al. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life  Sci  2018; 192: 46-54
9. Chen MF, Yang TT, Yeh LR, Chung HH, Wen YJ, Lee WJ, et al. Activation of imidazoline I-2B receptors by allantoin to increase glucose uptake into C₂C₁₂ cells. Horm Metab Res 2012; 44: 268-272.
10. Chen MF, Tsai. JT, Chen LJ, Wu TP, Yang JJ, Yin LT, et al. Antihypertensive action of allantoin in animals, Biomed. Res Int 2014; 2014: 690135.
11. Araújo LU, Grabe-Guimarães A, Mosqueira VC, Carneiro CM, Silva-Barcellos NM. Profile of wound healing process induced by allantoin. Acta Cir  Bras 2010; 25: 460-466.
12. Madrazo-Jiménez M, Rodríguez-Caballero Á, Serrera-Figallo MÁ, Garrido-Serrano R, Gutiérrez-Corrales A, Gutiérrez-Pérez JL, et al. The effects of a topical gel containing chitosan, 0,2% chlorhexidine, allantoin and despanthenol on the wound healing process subsequent to impacted lower third molar extraction. Med Oral Patol Oral Cir Bucal 2016; 21: 696-702.
13. Lee MY, Lee NH, Jung D, Lee JA, Seo CS, Lee H, et al. Protective effects of allantoin against ovalbumin (OVA)-induced lung inflammation in a murine model of asthma. Int Immunopharmacol 2010;10: 474-4780.
14. Florentino  IF, Silva DPB, Galdino PM, Lino RC, Martins JLR, Silva DM, et al. Antinociceptive and anti-inflammatory effects of Memora nodosa and allantoin in mice. J Ethnopharmacol 2016; 186: 298-304.
15. Ahn YJ, Park S J, Woo H, Lee HE, Kim HJ, Kwon G, et al. Effects of allantoin on cognitive function and hippocampal neurogenesis. Food Chem Toxicol 2014; 64: 210-216.
16. Yang TT, Chiu NH, Chung HH, Hsu CT, Lee WJ, Cheng JT. Stimulatory effect of allantoin on imidazoline I₁ receptors in animal and cell line. Horm Metab Res 2012;44: 879-884.
17. Chung HH, Lee KS, Cheng JT. Decrease of obesity by allantoin via imidazoline I 1-receptor activation in high fat diet-fed mice. Evid Based Complement Alternat Med 2013; 2013: 589309-589314.
18. Machado MV, Michelotti GA, Xie G, Almeida Pereira T, Boursier J, Bohnic B, et al. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS One 2015;10: 0127991
19. Rezazadeh. A, Yazdanparast. R, Molaei. M, Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress, J Biomed Sci 2012;19: 26.
20. Moslehi A, Nabavizadeh F, Zekri A, Amiri F. Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. Clin Exp Pharmacol Physiol  2017; 44: 207-212.
21. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41: 1313-1321.
22. Bozaykut P, Sahin A, Karademir B, Ozer NK. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis. Mech Ageing Dev 2016; 157: 17-29.
23. Moslehi A, Nabavizadeh F, Dehpour AR, Tavangar SM, Hassanzadeh G, Zekri A, et al. Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice. Acta Physiol Hung 2014;101: 341-352.
24. Lee S, Kim S, Hwang S, Cherrington NJ, Ryu DY. Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver disease. Oncotarget 2017; 8: 63370-63381.
25. Okada LSDRR, Oliveira CP, Stefano JT, Nogueira MA, Silva IDCGD, Cordeiro FB, et al. Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH - Proteomic and lipidomic insight. Clin Nutr 2017;5614: 30314-30320.
26. Arab JP, Arrese M, Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol 2018; 13: 321-350.
27. Go HK, Rahman MM, Kim GB, Na CS, Song CH, Kim JS, et al. Antidiabetic effects of Yam (Dioscorea batatas) and its active constituent, allantoin, in a rat model of streptozotocin-induced diabetes. Nutrients 2015; 7: 8532-8544.
28. Niu CS, Chen W, Wu HT, Cheng KC, Wen YJ, Lin KC, et al. Decrease of plasma glucose by allantoin, an active principle of yam (Dioscorea spp.), in streptozotocin-induced diabetic rats. J Agric Food Chem 2010; 58: 12031-12035.
29. Lin KC, Yeh LR, Chen LJ, Wen YJ, Cheng KC, Cheng JT. Plasma glucose-lowering action of allantoin is induced by activation of imidazoline I-2 receptors in streptozotocin-induced diabetic rats. Horm Metab Res 2012; 44: 41-46.
30. Lee JP, Chen W, Wu HT, Lin KC, Cheng JT. Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats. Horm Metab Res 2011; 43: 26-30.
31. Ai L, Xu Q, Wu C, Wang X, Chen Z, Su D, et al. A20 Attenuates FFAs-induced lipid accumulation in nonalcoholic steatohepatitis. Int J Biol Sci 2015;11: 1436-1446.
32. Meng Q, Duan XP, Wang CY, Liu ZH, Sun PY, Huo XK, et al. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation. Acta Pharmacol Sin 2017; 38: 69-79.
33. Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease Am J Clin Pathol 2007;127: 954-960.
34. Abd El-Haleim EA, Bahgat AK, Saleh S. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. World J Gastroenterol 2016; 22: 2931-2948.
35. Yamaguchi K, Itoh Y, Yokomizo C, Nishimura T, Niimi T, Fujii H, et al. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Lab Invest 2010; 90: 1169-1178.
36. Yamaguchi K, Itoh Y, Yokomizo C, Nishimura T, Niimi T, Umemura A, et al. Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice. Lab Invest 2011; 91: 609-618.
37. Weiss TS, Lupke M, Ibrahim S, Buechler C, Lorenz J, Ruemmele P, et al. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways. PLoS One 2017; 12: 0184282-0184290.
38. Amitani M, Cheng KC, Asakawa A, Amitani H, Kairupan TS, Sameshima N, et al. Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptors. Peer J 2015; 3: 1105-1112.
Iranian Journal of Basic Medical Sciences
Volume 22, Issue 7
July 2019
Pages 736-744

Files

Share

How to cite

Statistics